Clinical Indication

Paediatric Inflammatory Bowel Disease (Ulcerative Colitis and Crohn's Disease)


Full SCA


Date of classification

June 2014


Shared Care Agreement. Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.